|
Composite scores (rangea)
|
Routine cohort (n = 767)
|
Inception cohort (n = 105)
|
|---|
| |
Median
|
1st;3rd Quartile
|
Range
|
Median
|
1st;3rd Quartile
|
Range
|
|
DAS28 (0.5–9.1)
|
4.09
|
2.99;5.17
|
0.50–8.56
|
5.62
|
4.81;6.44
|
2.84–8.28
|
|
DAS28-CRP (1.0–8.5)
|
3.78
|
2.71;4.82
|
1.60–8.28
|
4.67
|
4.04;5.50
|
2.35–7.42
|
|
SDAI (0–86)
|
16.7
|
8.1;26.7
|
0.5–78.9
|
29.0
|
20.1;41.6
|
7.5–77.0
|
|
CDAI (0–76)
|
14.8
|
6.5;23.3
|
0–67.8
|
25.6
|
17.1;37.9
|
6.3–70.2
|
- aMaximum possible ranges of acute phase reactants assumed: 5–100 mm for erythrocyte sedimentation rate; 0–10 mg/dl for C-reactive protein (CRP). CDAI, Clinical Disease Activity Index; DAS, Disease Activity Score; SDAI, Simplified Disease Activity Index.
